New Zealand-Based Cancer Diagnostics Firm to Create 100 Jobs at PA Facility
01/30/2012
Pacific Edge is a cancer diagnostics company specializing in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer.
The firm's new 11,348-sq.-ft. space will serve as an office and processing facility for the analysis of its Cxbladder test, which uses the expression of genes in the patients' urine to detect the presence of bladder cancer accurately and non-invasively.
Planning and construction for the facility is currently underway. It will be located at the Hershey Center for Applied Research (HCAR), which is now building a "Knowledge Community" in partnership with Penn State University and the Penn State Milton S. Hershey Medical Center. This community offers tenants access to advanced technology and other research resources, and immerses them in a climate of innovation.
According to HCAR, Pacific Edge chose to bring its product to Hershey because of the Center's "direct engagement in nearly every aspect of the company's U.S. commercialization to date."
Most Read
-
-
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
-
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
-
Front Line: Manufacturers Look to Nontraditional Locations
Q3 2019
-
A Changing Food Manufacturing Industry
2017 Food Processing
-
The 3 Cs of Successful Site Selection: Company, Culture, and Community
Q2 2019
-
2019 Gold & Silver Shovel Awards: Recipients Garnered Large Job-Creating and Investment Projects in Diverse Industries
Q2 2019